Test positivity cutoff level of a high risk human papillomavirus test could be increased in routine cervical cancer screening
- 15 October 2008
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 123 (12), 2902-2906
- https://doi.org/10.1002/ijc.23839
Abstract
We present data on test positivity, relative sensitivity, rates of detection and relative specificity for primary human papillomavirus (HPV) testing with different cutoff levels for test positivity, in comparison to conventional cytology. In 2003–2004, 18,438 women were screened primarily with Hybrid Capture 2 (HC 2) assay, a test for oncogenic HPV DNA, and 21,446 with conventional cytology within the organised screening programme in Finland. A cytological triage test was performed for the HPV positives. Women with cytology equal to low grade squamous intraepithelial lesion (LSIL) or worse were referred for colposcopy. The relative sensitivity measured as relative risk (RR) of any cervical intraepithelial neoplasia (CIN) or cancer was 1.58 for the HPV test at the relative light units (rlu) ratio cutoff 1.00, in comparison to cytology. With the cutoff 3.00, all CIN 2+ lesions were detected. With cutoff 10.00, 2 of the 22 CIN 3+ lesions were missed. Relative specificity for HPV screening for any CIN was 92.6% at cutoff 1.00, 94.6% at cutoff 3.00 and 96.3% at cutoff 10.00. For CIN 3+ specificity estimates for these cutoffs were 92.1%, 94.1% and 95.8%, respectively. Used for routine screening as the sole test, the HPV test cutoff can be increased from the level recommended for clinical use. With HC 2, the detection rate at rlu ratio cutoff 10.00 is still at the level of high‐quality conventional screening. At that level, the false positive rate is reduced by about half and the specificity of the HPV test becomes equal to the average specificity of conventional cytology.Keywords
This publication has 22 references indexed in Scilit:
- Prevalence of oncogenic human papillomavirus infection in an organised screening population in FinlandInternational Journal of Cancer, 2008
- Screening with a primary human papillomavirus test does not increase detection of cervical cancer and intraepithelial neoplasia 3European Journal Of Cancer, 2008
- Chapter 9: Clinical applications of HPV testing: A summary of meta-analysesVaccine, 2006
- Human Papillomavirus Testing and Liquid-Based Cytology: Results at Recruitment From the New Technologies for Cervical Cancer Randomized Controlled TrialJNCI Journal of the National Cancer Institute, 2006
- Overview of the European and North American studies on HPV testing in primary cervical cancer screeningInternational Journal of Cancer, 2006
- Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: Design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST)International Journal of Cancer, 2006
- Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised settingBritish Journal of Cancer, 2005
- Human Papillomavirus Testing with the Hybrid Capture 2 Assay and PCR as Screening ToolsJournal of Clinical Microbiology, 2004
- Results of Human Papillomavirus DNA Testing with the Hybrid Capture 2 Assay Are ReproducibleJournal of Clinical Microbiology, 2002
- Comparative analysis of two ratesStatistics in Medicine, 1985